A dose ranging study of 2 different formulations of 15-valent pneumococcal conjugate vaccine (PCV15) in healthy infants

Background: Two new formulations of an investigational 15-valent pneumococcal conjugate vaccine (PCV15-A and PCV15-B) were developed using 2 different protein-polysaccharide conjugation processes and evaluated in separate phase I/II studies (NCT02037984 [V114-004] and NCT02531373 [V114-005]) to asse...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Hum Vaccin Immunother
Main Authors: Rupp, R., Hurley, D., Grayson, S., Li, J., Nolan, K., McFetridge, R.D., Hartzel, J., Abeygunawardana, C., Winters, M., Pujar, H., Benner, P., Musey, L.
Formato: Artigo
Idioma:Inglês
Publicado: Taylor & Francis 2019
Assuntos:
Research Paper
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6988874/
https://ncbi.nlm.nih.gov/pubmed/30689507
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2019.1568159
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares